Final Agenda and Sponsorship Deadline for Health 2.0 Europe

Health 2.0 Europe6-7 April 2010, Paris, France.
Health 2.0 Europe will be a unique conference, featuring the three integral components of Health 2.0 in a unique format where leading examples of Health 2.0 in North America will be compared and contextualized with the latest in European innovation. All speaking spots have now been filled but don't miss out on the opportunity to maximize your exposure at Health 2.0 Europe by Exhibiting or Sponsoring. The sponsorship deadline is Monday, February 22nd for your organization to gain unparalleled exposure in front of the the most influential leaders in healthcare. Every sponsorship package includes logo placement on Health 2.0 Europe website, marketing emails and conference materials. Join the distinguished sponsors, Akamai, Bupa, LEEM, Publicis, UCB to get your company in front of this distinguished audience.

Health 2.0 Europe will also examine the role of government in the spread of innovation and the impact of Health 2.0 on hospitals, payers and pharmaceutical companies. The confirmed prestigious speakers will be representing the following countries Germany, Switzerland, France, Italy, Spain, Great Britain, Ireland, Belgium, Hungary, Netherlands, Sweden, Denmark, and the US.

Health 2.0 Europe is also going to showcase the best of NEW European Health 2.0 companies in the Launch/Start-up Showcase.

Everyone will be invited to a dazzling reception at the famous Les Invalides, which has hosted royalty and emperors over the past 300 years.

The panels and topics will include: Keynote Addresses: The government view point – How does Health 2.0 fit into the various national IT strategies for EMRs, PHRs and national health and wellness?

Keynote Addresses from:

  • Etienne Caniard, French National Authority for Health France
  • Pieter Vos, Raad voor de Volksgezondheid en Zorg NL
  • Morten Elbæk Petersen, sundhed.dk Denmark

Search & Content - How does the best of vertical search technology resonate in a world where government programs provide significant amounts of health content?

Demonstrations & case studies from:

  • Segolène Ayme, Orphanet EU
  • Frankie Dolan, MedWorm UK
  • Célia Boyer, Health On the Net Foundation Swiss
  • West Shell, Healthline Networks america
  • Steven Krein, Organized Wisdom america
  • Berci Mesko, Webicina Hungary

Patients and Online Communities - The advancement and popularity of patient communities online is an international phenomenon. We’ll be examining communities in different cultures, languages and context, and see what impact they have on care delivery in different countries–and what the internationalization of information means for patients and doctors.

The patient perspective from:

  • Roberto Ascione, PagineMediche.it Italy
  • Gilles Frydman, ACOR america
  • Ben Heywood, PatientsLikeMe america
  • Neil Bacon, iWantGreatCare UK
  • Christian Angele, imedo Germany

Commentary:

  • Alexander Schachinger, Humboldt University Berlin Germany
  • Susannah Fox, Pew Internet america

Physicians and Online Communities - In the US, physician social networks are in some aspects replacing the function of traditional physician professional organizations. Physician activity online has a long tradition in Europe too.

The physician perspective from:

  • Daniel Palestrant, Sermo america
  • Miguel Cabrer, Medting Spain
  • Tim Ringrose, Doctors.net.uk UK
  • David Payne, British Medical Journal, Doc2Doc UK
  • Thomas Skoglund, Neurosurgic Sweden

Health 2.0 Tools - Consumer tools are an essential piece of the Health 2.0 landscape. Some of the most sophisticated drug, condition and treatment tools are giving patients as much if not more information than their physicians. Their use is already controversial in the US, but how is it playing out in different medical cultures across Europe?

  • Isabelle Adenot, French National Order of Pharmacists France
  • Roy Schoenberg, American Well america
  • David Doherty, 3G Doctor Ireland
  • Roni Zeiger, Google america
  • Sabine Pinedo, stichting Begeleide Zelfzorg (sBZ) NL
  • Neil Williams, Microsoft EU
  • Mohammad Al-Ubaydli, Patients Know Best UK
  • Joris Moolenaar, IPPZ NL
  • Sabine Donnai, Imperative Health UK
  • Alex Savic, Alensa AG Swiss

Hospitals, Payers and Health 2.0 - A look at how hospitals and payers are interacting with doctors and patients in the world of Health 2.0.

Demonstrations & commentary from:

  • Paul Hodgkin, PatientOpinion UK
  • Don Kemper, Healthwise america
  • Jean-Pascal Del Bano, Le Guide Santé France
  • Frank Neumann, BIG direkt gesund Germany
  • Emma Stanton, UK Department of Health UK

Pharma and Health 2.0 - How is Health 2.0 affecting Pharma? A look at how pharmaceutical companies are connecting with doctors and patients in new ways, and how Health 2.0 is changing the way they're conducting clinical research.

Discussion & case studies from:

  • Daniel Ghinn, Creation Interactive UK
  • Sylvie St-Laurent, Pfizer France
  • Len Starnes, Bayer Health Germany
  • Sophie Kune, ParleAvecElles France
  • René Hansen, UCB Belgium
  • Gábor Gyarmati, Webbeteg Ltd. Hungary

Looking Ahead for Health 2.0 - Discoveries and lessons from the conference.

Discussion with:

  • Annabel Bentley, Bupa UK
  • Jean Louis Laporte, TribuCancer France

For further information and registration, please visit:
http://www.health2con.com/paris2010/

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...